MedPath

A clinical trial to study the effect of prewarming on intraoperative blood loss and transfusion requirements in Total Hip Arthroplasty surgeries.

Phase 3
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: M879- Osteonecrosis, unspecified
Registration Number
CTRI/2021/04/033265
Lead Sponsor
AIIMS JODHPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients scheduled for elective primary unilateral total hip arthroplasty under combined spinal epidural technique will be included in the study.

Exclusion Criteria

1. Patients planned for bilateral or revision total hip arthroplasty.

2. Patients with bleeding or coagulation disorders.

3. Patients on anticoagulants or antiplatelet drugs before surgery.

4. Patients with severe cardiovascular disorders.

5. Patients with thyroid disorders.

6. Patients with skin lesions or history of hypersensitivity to skin contact devices.

7. Patients with use of a transdermal medication patch.

8. Pre-existing preoperative hypothermia( <35.5degC) or hyperthermia( >37.5degC)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath